Mortada Hatan, Alaqil Sultan, Jabbar Imtinan Al, Alhubail Fatimah, Pereira Nicolas, Hong Joon Pio, Alshomer Feras
Division of Plastic Surgery, Department of Surgery, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Department of Plastic Surgery & Burn Unit, King Saud Medical City, Riyadh, Saudi Arabia.
Arch Plast Surg. 2024 Aug 6;51(5):510-526. doi: 10.1055/a-2334-9260. eCollection 2024 Sep.
Lipedema is a chronic, incurable disorder characterized by painful fat accumulation in the extremities. While the application of liposuction in lipedema management has become increasingly popular, the safety and effectiveness of this approach remain contentious. Our systematic review and meta-analysis aimed to assess various liposuction modalities in lipedema management to verify their safety and efficacy. In-line with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, we performed a comprehensive literature review from inception until March 2023 using the following electronic databases: CENTRAL, MEDLINE, Google Scholar, and EMBASE. From the 562 initially identified articles, 20 met our inclusion/exclusion criteria for evaluation. Our review encompassed 14 prospective cohort studies, 3 retrospective studies, 2 case series, and 1 cross-sectional study. A meta-analysis of nine articles revealed a notable improvement in the quality of life, pain, pressure sensitivity, bruising, cosmetic impairment, heaviness, walking difficulty, and itching among lipedema patients who underwent liposuction. Although complications such as inflammation, thrombosis, seroma, hematoma, and lymphedema-related skin changes were reported, severe complications were rare. Crucially, no instances of shock, recurrence, or mortality were reported. Liposuction is a safe and beneficial therapeutic intervention for managing lipedema symptoms and enhancing quality of life. However, the impact of liposuction on secondary lymphedema remains unreported in the literature. Further high-quality, large-scale trials are necessary to assess the safety and effectiveness of different liposuction modalities. These studies will contribute valuable insights to optimize liposuction as a therapeutic option for individuals with lipedema. I, risk/prognostic study.
脂肪性水肿是一种慢性、无法治愈的疾病,其特征是肢体出现疼痛性脂肪堆积。虽然抽脂术在脂肪性水肿治疗中的应用越来越普遍,但这种方法的安全性和有效性仍存在争议。我们的系统评价和荟萃分析旨在评估抽脂术在脂肪性水肿治疗中的各种方式,以验证其安全性和有效性。
按照系统评价和荟萃分析的首选报告项目指南,我们从开始到2023年3月使用以下电子数据库进行了全面的文献综述:CENTRAL、MEDLINE、谷歌学术和EMBASE。
在最初识别的562篇文章中,有20篇符合我们的纳入/排除标准以供评估。我们的综述包括14项前瞻性队列研究、3项回顾性研究、2个病例系列和1项横断面研究。对9篇文章的荟萃分析显示,接受抽脂术的脂肪性水肿患者在生活质量、疼痛、压力敏感性、瘀伤、美容损伤、沉重感、行走困难和瘙痒方面有显著改善。虽然报告了炎症、血栓形成、血清肿、血肿和淋巴水肿相关皮肤变化等并发症,但严重并发症很少见。至关重要的是,未报告休克、复发或死亡病例。
抽脂术是一种安全有益的治疗干预措施,可用于管理脂肪性水肿症状并提高生活质量。然而,抽脂术对继发性淋巴水肿的影响在文献中尚未报道。需要进一步进行高质量、大规模的试验来评估不同抽脂方式的安全性和有效性。这些研究将为优化抽脂术作为脂肪性水肿患者的治疗选择提供有价值的见解。
I,风险/预后研究。